PUBLISHER: IMARC | PRODUCT CODE: 1540963
PUBLISHER: IMARC | PRODUCT CODE: 1540963
The global intracranial pressure monitoring market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
Intracranial pressure (ICP) monitoring is utilized in neurosurgery and neurology for measuring the pressure inside the skull. It can be performed using either invasive or non-invasive techniques. Amongst these, invasive techniques, such as ventriculostomy and micro transducers, involve drilling a hole in the skull using a burr hole or a twist drill technique for inserting the device. The device is connected to transducers for sending measurements and projecting cerebrospinal fluid (CSF) waveform. On the other hand, non-invasive techniques are generally utilized for avoiding complications of hemorrhages and infections associated with the former technique. They include transcranial Doppler, tympanic membrane displacement, optic nerve sheath diameter, magnetic resonance imaging (MRI) and fundoscopy. Nowadays, health professionals prefer using ICP monitors, clinical examination, and brain imaging to provide better results.
Owing to the increasing cases of coronavirus disease (COVID-19), the need for providing optimum care to patients under critical conditions is escalating around the world. This, in turn, is strengthening the ICP monitor market growth, as these devices are used for monitoring patients under intensive care. Apart from this, the rising number of individuals suffering from traumatic brain injury (TBI), represents another growth-inducing factor impelling market growth. Additionally, the increasing prevalence of autoimmune, cardiovascular and sleep disorders has catalyzed the demand for ICT monitors to provide early and effective treatment. Furthermore, governments of several countries are spending on improving the healthcare infrastructure and critical care centers, which is expected to boost the sales of these monitors. Additionally, manufacturers are also focusing on the introduction of an ICP monitoring device for home use. Such innovations are expected to create a positive outlook for the market growth in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global intracranial pressure monitoring market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, technology, monitoring type, application and end-user.
Monitors
Probes
Catheters and Kits
Other Accessories
Invasive
External Ventricular Drainage (EVD)
Microtransducer ICP Monitoring
Non-invasive
Transcranial Doppler Ultrasonography
Tympanic Membrane Displacement
Optic Nerve Sheath Diameter
MRI/CT
Others
Intraventricular
Intraparenchymal
Epidural
Others
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Others
Hospitals
Home Care
Trauma Centers
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being DePuy Synthes (Johnson & Johnson), HeadSense Medical Ltd., Integra Lifesciences Corporation, LINET Ltd., Medtronic plc, Natus Medical Incorporated, Raumedic AG (Rehau), Sophysa, Spiegelberg Gmbh (SHS), etc.